UBE2M and urothelial carcinoma: UBE2M, as an oncogene, has been confirmed to be overexpressed in several tumors, including osteosarcoma, urothelial carcinoma, cholangiocarcinoma, lung cancer, and HCC [16–18, 26, 27].